XML 15 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2020 $ (11,315)   $ 1 $ 451 $ 156 $ (11,923)
Beginning Balance, Shares at Dec. 31, 2020   22,012,499        
Beginning Balance at Dec. 31, 2020   $ 45,356        
Beginning Balance, Shares at Dec. 31, 2020     15,957,821      
Issuance of Series A and Series B convertible preferred stock, net of issuance costs   $ 124,712        
Issuance of Series A and Series B convertible preferred stock, net of issuance costs, Shares   19,083,979        
Preferred stock converted into shares of common stock 170,068   $ 4 170,064    
Preferred stock converted into shares of common stock, Shares   (41,096,478)        
Preferred stock converted into shares of common stock   $ (170,068)        
Preferred stock converted into shares of common stock, Shares     25,212,548      
Initial public offering of common shares, net of $21,728 of issuance costs 254,271   $ 1 254,270    
Initial public offering of common shares, net of $21,728 of issuance costs, Shares     13,800,000      
Exercises of stock options and vesting of restricted stock 5     5    
Exercises of stock options and vesting of restricted stock, Shares     144,360      
Stock-based compensation 1,890     1,890    
Unrealized gain (loss) on investments (168)       (168)  
Net loss (13,150)         (13,150)
Ending Balance at Jun. 30, 2021 401,601   $ 6 426,680 (12) (25,073)
Ending Balance, Shares at Jun. 30, 2021     55,114,729      
Beginning Balance at Mar. 31, 2021 408,006   $ 6 425,435 2 (17,437)
Beginning Balance, Shares at Mar. 31, 2021     55,042,550      
Exercises of stock options and vesting of restricted stock $ 2     2    
Exercises of stock options and vesting of restricted stock, Shares 72,179          
Stock-based compensation $ 1,243     1,243    
Unrealized gain (loss) on investments (14)       (14)  
Net loss (7,636)         (7,636)
Ending Balance at Jun. 30, 2021 401,601   $ 6 426,680 (12) (25,073)
Ending Balance, Shares at Jun. 30, 2021     55,114,729      
Beginning Balance at Dec. 31, 2021 382,130   $ 6 429,824 (244) (47,456)
Beginning Balance, Shares at Dec. 31, 2021     55,441,926      
Exercises of stock options and vesting of restricted stock 166     166    
Exercises of stock options and vesting of restricted stock, Shares     250,626      
Issuance of common stock under employee stock purchase plan 225     225    
Issuance of common stock under employee stock purchase plan, Shares     24,209      
Stock-based compensation 4,977     4,977    
Unrealized gain (loss) on investments (2,071)       (2,071)  
Net loss (28,264)         (28,264)
Ending Balance at Jun. 30, 2022 357,163   $ 6 435,192 (2,315) (75,720)
Ending Balance, Shares at Jun. 30, 2022     55,716,761      
Beginning Balance at Mar. 31, 2022 370,309   $ 6 432,346 (1,322) (60,721)
Beginning Balance, Shares at Mar. 31, 2022     55,618,326      
Exercises of stock options and vesting of restricted stock 4     4    
Exercises of stock options and vesting of restricted stock, Shares     74,226      
Issuance of common stock under employee stock purchase plan 225     225    
Issuance of common stock under employee stock purchase plan, Shares     24,209      
Stock-based compensation 2,617     2,617    
Unrealized gain (loss) on investments (993)       (993)  
Net loss (14,999)         (14,999)
Ending Balance at Jun. 30, 2022 $ 357,163   $ 6 $ 435,192 $ (2,315) $ (75,720)
Ending Balance, Shares at Jun. 30, 2022     55,716,761